Abstract

With N-(5-phenyl-1,3,4-oxadiazol-2-yl)-benzamide (HL1) as the first ligand, three new luminescent europium complexes Eu2Na2(L1)6(OH)(2).2C2H5OH.2CHCl3 (1), Eu(L1)3(phen) (phen = 1,10-phenanthroline) (2) and Eu2Na2(L1)6(L2)2(OH)(2).8CHCl3 [L2 = 2,5-bis(2-pyridyl)-1,3,4-oxadiazole] (3) have been prepared and structurally characterized. Each ligand L1 coordinates with a Eu3+ ion through a carbonyl oxygen atom and oxadiazol nitrogen atom, the coordination geometry at europium is a distorted square antiprism. Complexes 1 and 3 have centrosymmetric dimeric structural features with OH- as the bridging ligand, while 2 is mononuclear with phen as the neutral ligand. All these complexes show efficient red emissions typical of Eu3+ ions at room temperature, the overall quantum yields of complexes 1, 2 and 3 were 0.15, 0.37 and 0.23, respectively. Using Eu(L1)3(phen) as the emitting material, an electroluminescent device with the structure ITO/TPD (30 nm)/Eu(L1)3(phen): TPD (1 : 3, 50 nm)/AlQ (30 nm)/Mg(0.9)Ag(0.1)/Ag was fabricated. The device emits sharp red light originating from europium complex, demonstrating that Eu(L1)3(phen) is a promising red emitter with good electron-transporting property.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.